Elanco delivered second-quarter results that included organic revenue growth and operating margins of 8% and 8.6%, respectively. The pet segment grew 11%, while the farm animal division was up 5%. Management raised its revenue and earnings-per-share outlook for the full year.
Secular growth of global pet ownership should provide a continuous tailwind to the demand for Elanco products.
Regulatory scrutiny on antibiotics used in meat production may limit the total market of Elanco’s feed additive products.
|
Metric
|
ELAN
|
ZTS
|
MRK
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.57 | 11.04 | 40.06 |
Price/Book Value | 1.68 | 9.56 | 7.57 |
Price/Sales | 2.20 | 3.29 | 4.79 |
Price/Cash Flow | 19.32 | 9.76 | 14.40 |
|
Metric
|
ELAN
|
ZTS
|
MRK
|
|---|---|---|---|
Quick Ratio | 0.91 | 1.57 | 0.71 |
Current Ratio | 2.05 | 3.08 | 1.32 |
Interest Coverage | 0.33 | 14.29 | 4.28 |
|
Metric
|
ELAN
|
ZTS
|
MRK
|
|---|---|---|---|
Return on Assets (Normalized) | 0.43% | 18.54% | 6.27% |
Return on Equity (Normalized) | 0.88% | 69.53% | 16.68% |
Return on Invested Capital (Normalized) | 2.39% | 23.41% | 9.82% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|?gDzh?? | LOCK|J>%& | $72B | |||
| Haleon PLC ADR
HLN
| LOCK|l!$#>> | LOCK|!@< | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|nfB%#lf | LOCK|Z&^$ | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|GG?MBRv | LOCK|@xp | $30B | |||
| Viatris Inc
VTRS
| LOCK|fbm%V<# | LOCK|<ln | $19B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|g%?ZynY | LOCK|&% | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|f<?$%%c | LOCK|Xh | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|S%$#?K | LOCK|qDT$ | $3B | |||
| Perrigo Co PLC
PRGO
| LOCK|@Cz>^%D | LOCK|s&L | $2B |
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/adf521c2-d9af-477d-a6bc-03ec7ca34c40.jpg)
United States